These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8533554)

  • 21. New skeletal muscle relaxants.
    Caldwell JE
    Int Anesthesiol Clin; 1995; 33(1):39-60. PubMed ID: 7635557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of intermediate acting muscle relaxants by infusion: the future.
    Mirakhur RK; McCourt KC; Kumar N
    Acta Anaesthesiol Belg; 1997; 48(1):29-34. PubMed ID: 9099306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical pharmacology of mivacurium chloride (BW B1090U) infusion: comparison with vecuronium and atracurium.
    Ali HH; Savarese JJ; Embree PB; Basta SJ; Stout RG; Bottros LH; Weakly JN
    Br J Anaesth; 1988 Nov; 61(5):541-6. PubMed ID: 2905143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Newer neuromuscular blocking drugs. An overview of their clinical pharmacology and therapeutic use.
    Mirakhur RK
    Drugs; 1992 Aug; 44(2):182-99. PubMed ID: 1382013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical pharmacology of mivacurium chloride: a review.
    Basta SJ
    J Clin Anesth; 1992; 4(2):153-63. PubMed ID: 1373287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Histamine liberation in the recovery unit after administration of mivacurium by continuous infusion].
    de la Cruz Pérez C; Cruz Mañas J
    Rev Esp Anestesiol Reanim; 1998 Feb; 45(2):77-8. PubMed ID: 9580530
    [No Abstract]   [Full Text] [Related]  

  • 27. Mivacurium after atracurium in children.
    Goudsouzian NG; Denman W; Matta E
    Anesth Analg; 1994 Aug; 79(2):345-9. PubMed ID: 7639377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mivacurium in pediatric anesthesia].
    Hofmockel VR; Pohl B; Benad G
    Anaesthesiol Reanim; 1996; 21(1):11-3. PubMed ID: 8901179
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of 51W89 by infusion--a comparison with atracurium--preliminary communication.
    Mellinghoff H; Diffenbach C; Buzello W
    Acta Anaesthesiol Scand Suppl; 1995; 106():95. PubMed ID: 8533556
    [No Abstract]   [Full Text] [Related]  

  • 31. Spontaneous recovery or evoked reversal of neuromuscular block.
    Mirakhur RK
    Acta Anaesthesiol Scand Suppl; 1995; 106():62-5. PubMed ID: 8533549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peripheral link model as an alternative for pharmacokinetic-pharmacodynamic modeling of drugs having a very short elimination half-life.
    Laurin J; Donati F; Nekka F; Varin F
    J Pharmacokinet Pharmacodyn; 2001 Feb; 28(1):7-25. PubMed ID: 11253615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Performance assessment of an adaptive model-based feedback controller: comparison between atracurium, mivacurium, rocuronium and vecuronium.
    Kansanaho M; Olkkola KT
    Int J Clin Monit Comput; 1996 Nov; 13(4):217-24. PubMed ID: 9080242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nondepolarizing neuromuscular blocking drugs and train-of-four fade.
    McCoy EP; Connolly FM; Mirakhur RK; Loan PB; Paxton LD
    Can J Anaesth; 1995 Mar; 42(3):213-6. PubMed ID: 7743572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.
    Rimaniol JM; Dhonneur G; Sperry L; Duvaldestin P
    Anesth Analg; 1996 Oct; 83(4):808-13. PubMed ID: 8831326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of recurarization during retransfusion of autologous blood withdrawn after injection of muscle relaxants: a comparison of rocuronium and mivacurium.
    Rohling RG; Rentsch KM; Beck-Schimmer B; Fuchs-Buder T
    J Clin Anesth; 2003 Mar; 15(2):85-90. PubMed ID: 12719045
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiovascular effects and histamine-releasing properties of 51W89 in patients receiving nitrous oxide/opioid/barbiturate anesthesia.
    Lien CA; Belmont MR; Abalos A; Eppich L; Quessy S; Abou-Donia MM; Savarese JJ
    Anesthesiology; 1995 May; 82(5):1131-8. PubMed ID: 7537945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mivacurium--a new muscle relaxant compared with atracurium and vecuronium].
    Scholz J; von Knobelsdorff G; Peters K; Kycia B; Schulte am Esch J
    Anaesthesiol Reanim; 1997; 22(4):95-9. PubMed ID: 9376044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potency of mixtures of mivacurium and atracurium or vecuronium.
    Kopman AF
    Anesth Analg; 1995 Jul; 81(1):207-8. PubMed ID: 7598267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.